Rincón-León Héctor A, Navarro-Fuentes Karla R
Coordinación Delegacional de Investigación, Instituto Mexicano del Seguro Social, Tapachula, Chiapas, México.
Rev Med Inst Mex Seguro Soc. 2016 Jan-Feb;54(1):32-41.
The treatment of nosocomial infections is hindered by the increasing antimicrobial resistance pattern of germs that cause them. The objective was to assess trends in resistance of bacteria isolated from nosocomial infections.
Retrospective study from 2009 to 2012 on a third level hospital in Chiapas.
1300 germs were obtained, 62.3 % Gram negative bacteria, 22.8 % Gram positive and 14.9 % yeasts; imipenem resistance of P. aeruginosa went from 47.1 to 60.5 %, E. coli showed an increased resistance to aztreonam, cefepime and ceftazidime, A. baumannii increased resistance to amikacin, cefepime, ceftazidime and ciprofloxacin. Klebsiella pneumoniae decreased its resistance to amikacin and piperacillin/tazobactam; vancomycin resistance ranges from 3.6 to 25.5 %.
Gram negative organisms predominated, showing increasing trends in antimicrobial resistance. There was a proportional increase in the incidence of infection from E. coli, C. tropicalis and S. haemolyticus. It is essential to have programs and plans for the rational and evidence-based use of antimicrobials, as well as dissemination and adherence to clinical practice guidelines and the implementation of innovative programs for the prevention and control of nosocomial infections, isolation techniques and general care.
医院感染的治疗因引发感染的病菌抗菌耐药模式不断增加而受到阻碍。目的是评估从医院感染中分离出的细菌的耐药趋势。
对恰帕斯州一家三级医院2009年至2012年进行回顾性研究。
共获得1300株病菌,其中革兰氏阴性菌占62.3%,革兰氏阳性菌占22.8%,酵母菌占14.9%;铜绿假单胞菌对亚胺培南的耐药率从47.1%升至60.5%,大肠埃希菌对氨曲南、头孢吡肟和头孢他啶的耐药性增加,鲍曼不动杆菌对阿米卡星、头孢吡肟、头孢他啶和环丙沙星的耐药性增加。肺炎克雷伯菌对阿米卡星和哌拉西林/他唑巴坦的耐药性降低;万古霉素耐药率在3.6%至25.5%之间。
革兰氏阴性菌占主导,抗菌耐药呈上升趋势。大肠埃希菌、热带假丝酵母菌和解脲脲原体感染的发生率成比例增加。制定合理且基于证据的抗菌药物使用计划和方案,以及传播并遵守临床实践指南,实施预防和控制医院感染、隔离技术及一般护理的创新方案至关重要。